This DSIR recognition for company's in-house R&D Unit make it eligible for receiving funds for R&D purpose from various government departments and agencies
The cardiomyopathies market in the 68M is set to grow at a CAGR of 12.1%
Purchase agreement with ViewRay will make state-of-the art precision radiation therapy available in China
Biocytogen will provide a license to Hansoh Pharma for their selected fully human antibody molecules
Passengers arriving from 6 high-risk countries are now mandatorily required to upload their negative RT-PCR test
The company is one of the most profitable companies manufacturing speciality chemicals in India
Tafasitamab is conditionally approved by both the U.S. Food and Drug Administration and European Medicines Agency
Yonghe as the CDMO partner will provide production process development and cGMP manufacturing services for Ablaze
Centre and states need to work in tandem and in a collaborative spirit as was done during the previous surges for COVID-19 prevention and management
First PARP inhibitor and new hormonal agent combination approved for these patients in Europe
Subscribe To Our Newsletter & Stay Updated
